Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Superiority of Intensity Modulated Radiotherapy in Recurrent T1-2 Nasopharyngeal Carcinoma

NCT02113423 is registered in ClinicalTrials.gov with Fujian Cancer Hospital as lead sponsor.

NCT NCT02113423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02113423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Superiority of Intensity Modulated Radiotherapy in Recurrent T1-2 Nasopharyngeal Carcinoma
Lead sponsor
Fujian Cancer Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 31, 1996
Completion date
March 31, 2011
Enrollment
168 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nasopharyngeal cancer recurrent